In honor of Star Wars Day, get our Grantwriting Starter Bundle for a special price this week only.

Fiscal Year 2022 Application and Funding Data Based on Investigator Career Phase

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

Recently-released NIH data regarding applicants for fiscal year 2022 (FY22) reveal that NIH supported an additional 1,609 Early Stage Investigators (ESI) as Principal Investigators on new R01s. This marks the seventh consecutive FY where the number of ESIs supported on new R01s has increased. A total of 5,435 ESI applicants applied (funding rate: 29.6%) and 3,466 were discussed.

The data provide breakdowns by gender, race, ethnicity, and disability for ESIs, new (not early), at-risk, and established investigators. In FY22, more applications were received from and awarded to male researchers than female researchers across all career stages. There were more female ESI applicants and awardees in FY22 compared to FY21 and 20. The number of Black/African American ESI applicants was also higher in FY22 compared to FY21 and 20. However, the discussion rate was lower for Black/African American researchers across all career stages in FY22 compared to their White and Asian counterparts and the absolute number of Black/African American applicants and awardees remains markedly lower than white and Asian researchers.     

Discussion rates were higher for Hispanic or Latino researchers in the later career stages compared to non-Hispanic or Latino researchers. Less than 2% of applicants reported having a disability. The discussion and funding rates were generally lower for PIs who identified as having a disability compared to those who did not.

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter